SMD > Institute of Cancer > Staff > Norbert Avril

... Bienert M, McCook B, Carr B, Geller D, Sheetz M, Tutor C, Amesur N, Avril N. Yttrium-90 microsphere treatment of unresectable liver metastases: changes in F-18 FDG uptake and tumor size on PET/CT. Eur J Nucl Med Mol...
http://www.cancer.qmul.ac.uk/staff/avril.html

 

Ovacome : Medical updates

Home Ovarian cancer Ovacome Christmas Cards 2008 Ovacome Calendar 2009 Resources Real-life stories Newsletters News What you can do About us ... In addition, I am also on a clinical trial for yttrium 90 which will, hopefully,...
http://www.ovacome.org.uk/Newsletters/Summer2000/Medicalupdates

 

TIME Europe |Special Report: The Future of Medicine | 1/15/2001

TIME Europe Home / Europe / Middle East / Africa / World / Digital Europe / Business / Travel & Arts / Photo Essays / TIME Trails / Magazine / Archive / Fast Forward ... IDEC Pharmaceuticals in San Diego has just completed final rounds of...
http://www.time.com/time/europe/magazine/2001/0115/cover_cures3.html

 

BMJ Editorial

Editor's Choice | / This Week in BMJ | / Press releases / BMJ No 7116 Volume 315 ... 18 Sharp P S, Fallon T J, Brazier O J, Sandler L, Joplin G F, Kohner E M. Long-term follow-up of patients who underwent yttrium-90 pituitary...
http://www.bmj.com/archive/7116/7116e1.htm

 

A-Z of medicines research

Home Search Contacts Help / A-Z of medicines research / A B C D E F G H I J K L M / N O P Q R S T U V W X Y Z / A-Z of medicines research - Contents / ==================== CONTENTS / Foreword by the Director General of the ABPI ... This is coupled...
http://www.abpi.org.uk/publications/publication_details/azResearch/l1.asp

 

Cancer Research UK : Non-Hodgkin lymphoma symptoms and treatment

... The antibody Rituximab, which recognises the CD20 B-cell marker, can be used alone for the treatment of low grade B-cell lymphoma or in combination with chemotherapy, particularly for aggressive types.5 An anti-CD20 antibody can also be...
http://info.cancerresearchuk.org/cancerstats/types/nhl/symptomstreatment/

 

www.curesearch.org/for_parents_and_families/protocols/index.aspx

Newly Diagnosed / Getting beyond cancer treatment involves a focus on wellness and ways to improve quality of life. ... ADVL0013   -   A Phase I Study of 90YTTRIUM-IBRITUMOMAB TIUXETAN (IDEC-Y2B8, YTTRIUM (90)-ANTI-CD20)...
http://www.curesearch.org/for_parents_and_families/protocols/index.aspx

 

Medical Buzz - Your source for medical news.

Start | / Archive | / Services | / About Us | / Contact / Search News / All sources / NBC4.TV / American Medical / American Health / AP Health / BBC Health / eMediaWire / eMediaWire / Fighting cancer / Health and Home / Health News / Kansas City...
http://www.medical-buzz.com/a2006-7-10.html

 

Clinical Trials Monitor Summary

Skip to Secondary Navigation Links / •  Back to Clinical Trials Monitor ... A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, Yttrium-90 Ibritumomab Tiuxitan) for Patients with Incomplete...
http://www.multiplemyeloma.org/clinical_trials/4.06.php

 

Clinical Cancer Research -- Table of Contents (August 15 2005, 11 [16])

... High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker...
http://clincancerres.aacrjournals.org/content/vol11/issue16/

 
< | 1 | 2 | 3 | 4 | 5 | 6 | 7 | >